Patents for C12P 21 - Preparation of peptides or proteins (112,499)
09/1993
09/02/1993WO1993017041A1 Car receptors and related molecules and methods
09/02/1993WO1993017030A1 Immunological detection of organophosphates
09/02/1993WO1993016725A1 Early antigen for autoimmune diabetes
09/02/1993WO1993016723A1 Purified vacuolating toxin from helicobacter pylori and methods to use same
09/02/1993WO1993016722A1 Antigens protective against echinococcus granulosus infection and vaccines containing such antigens
09/02/1993WO1993016709A1 Therapeutic domains of von willebrand factor
09/02/1993CA2131028A1 Hepatitis c virus peptides
09/02/1993CA2130997A1 Early antigen for autoimmune diabetes
09/02/1993CA2117608A1 Endo-1,4-beta-d-glucanase
09/02/1993CA2117491A1 Car receptors and related molecules and methods
09/01/1993EP0558024A2 Novel vector having promoter that is inducible by methanol and/or glycerol
09/01/1993EP0557966A1 Prostaglandin E receptors, their DNA and production
09/01/1993EP0557954A2 A process for producing epsilon-poly-L-lysine
09/01/1993EP0557897A1 Antigen binding proteins and methods for their production
09/01/1993EP0557663A1 Assessment of bone fragility and prediction of osteoporotic fracture risk using a quantitative determination of circulating under-carboxylated osteocalcin
09/01/1993EP0557535A1 HUMAN MONOCLONAL ANTIBODY AGAINST GLYCOPROTEIN IIb/IIIa
09/01/1993EP0557455A1 Recombinant feline coronavirus s proteins
09/01/1993EP0557451A1 Characterization of platelet aggregation disorders
09/01/1993EP0557442A1 Antithrombosis agents
09/01/1993EP0557418A1 A $g(b)-TYPE TRANSFORMING GROWTH FACTOR
09/01/1993EP0557388A1 Diagnosis and treatment of multiple sclerosis
09/01/1993EP0557300A1 Bispecific antibodies, method of production, and uses thereof
09/01/1993EP0542929A4 Glycogen biosynthetic enzymes in plants
09/01/1993EP0241539B1 Expression systems for overproduction of desired proteins
09/01/1993CN1021973C Production of proteins in procaryotes
08/1993
08/31/1993US5241051 Secreted by human erythroblastoid cells
08/31/1993US5241049 Neutrophil chemoattractants
08/31/1993US5240911 Method of reducing blood sugar levels using a hypoglycemic agent
08/31/1993US5240848 Cloning; genetic engineering
08/31/1993US5240847 Cloned gene
08/31/1993US5240846 Gene therapy vector for cystic fibrosis
08/31/1993US5240834 Solubilization of protein after bacterial expression using sarkosyl
08/31/1993US5240833 Method for the production of monoclonal antibodies directed to tumor-associated gangliosides and fucogangliosides
08/31/1993US5240832 Culturing cells transformed with vectors to produce thyroid stimulating hormone
08/31/1993CA1321766C Process for producing cell having high productivity of protein and process for preparing protein by using the cell
08/31/1993CA1321765C Immunodiagnostic assays using chimeric antigens
08/31/1993CA1321764C Dna sequence to target proteins to the mammary gland for efficient secretion
08/31/1993CA1321763C Monoclonal antibody specific to human pancreatic phospholipase a
08/29/1993CA2089966A1 Antigen binding proteins and methods for their production
08/25/1993EP0557076A1 Selective removal of N-terminal extensions from folded insulin precursors using dipeptidyl-aminopeptidase-1
08/25/1993EP0556496A2 Antibodies against tumor-associated mucin glycoprotein
08/25/1993EP0556434A2 Process for economically producing a protein by using silkworms
08/25/1993EP0556395A1 Novel cytokine
08/25/1993EP0556345A1 Retroviral vectors useful for gene therapy.
08/25/1993EP0556320A1 Monoclonal antibodies to hepatitis c virus and method for using same
08/25/1993EP0556292A1 Hepatitis c virus asialoglycoproteins
08/25/1993EP0556207A1 Modified human tnfalpha (tumor necrosis factor alpha) receptor
08/25/1993EP0556182A1 Dna capable of site-specific integration into mycobacteria
08/25/1993EP0556171A1 Growth hormone antagonists
08/25/1993EP0555405A4 Specific detection of antibodies to human t-cell leukemia viruses
08/25/1993EP0199801B1 Methods for protein binding enzyme complementation assays
08/25/1993CA2090278A1 Prostaglandin e receptors, their dna and production
08/24/1993US5239060 Muscular dystrophy protein, dystrophin
08/24/1993US5238836 Genetic engineering; isolated DNA sequences
08/24/1993CA1321563C Light inducible promoter
08/19/1993WO1993016193A1 Cell adhesion inhibiting antibody and cell adhesion inhibitor containing the same
08/19/1993WO1993016192A1 Humanised antibody against hepatitis
08/19/1993WO1993016190A1 Bacterial macromolecule extract, method for preparing same and pharmaceutical composition containing said extract
08/19/1993WO1993016185A2 Biosynthetic binding protein for cancer marker
08/19/1993WO1993016184A1 Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5
08/19/1993WO1993016179A1 MAMMALIAN Sos - A REGULATOR/EFFECTOR OF TYROSINE KINASE SIGNALLING
08/19/1993WO1993016107A1 Improved alpha interferon composition and method for its production from human peripheral blood leukocytes
08/19/1993WO1993016099A2 Dna sequences encoding novel growth/differentiation factors
08/19/1993WO1993016096A1 Recombinant gibberellin dna and uses thereof
08/19/1993WO1993015762A1 Feline infectious peritonitis vaccine and method of preparation
08/19/1993WO1993015755A1 Protease-resistant thrombomodulin analogs
08/19/1993WO1993015608A1 Prevention of retinal injury and degeneration by specific factors
08/19/1993CA2372813A1 Biosynthetic binding protein for cancer marker
08/19/1993CA2129533A1 Improved alpha interferon composition and method for its production from human peripheral blood leukocytes
08/19/1993CA2129517A1 Recombinant gibberellin dna and uses thereof
08/19/1993CA2129445A1 Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5
08/19/1993CA2129370A1 Protease-resistant thrombomodulin analogs
08/19/1993CA2128698A1 Feline infectious peritonitis vaccine and method of preparation
08/19/1993CA2106854A1 Extract of bacterial macromolecules, a process for its preparation and a pharmaceutical composition containing the same
08/19/1993CA2089541A1 Selective removal of n-terminal extensions from folded insulin precursors using dipeptidyl-aminopeptidase-1
08/18/1993EP0556152A1 Pyridinium derivatives and their use in determining connective tissue disorders in humans and animals
08/18/1993EP0556111A1 Hybrid protein complexes, their process of preparation, and their applications as an agent in diagnostic and in the therapeutic field or as a reagent relevant in medical approaches
08/18/1993EP0556106A2 Antibody binding to human aldose reductase and its uses
08/18/1993EP0555989A1 TGF-beta induced gene and protein
08/18/1993EP0555880A2 The CD40CR receptor and ligands therefor
08/18/1993EP0555785A1 Smooth muscle mitogen and DNA coding therefor
08/18/1993EP0555454A1 Cell culture process and medium for the growth of adherent animal cells
08/18/1993EP0555435A1 DNA SEQUENCE ENCODING BOVINE $g(a)-LACTALBUMIN AND METHODS OF USE
08/18/1993EP0555425A1 Antibodies to streptolysin o derivatives and variants
08/18/1993EP0555405A1 Specific detection of antibodies to human t-cell leukemia viruses
08/18/1993EP0555397A1 Polypeptide with kd hmfg differentiation antigen binding specificity
08/18/1993EP0555370A1 Methods and applications for efficient genetic suppressor elements
08/18/1993EP0555363A1 Identification of a suppressor of atherogenic apolipoprotein
08/18/1993EP0555286A1 Cell growth inhibitors
08/18/1993EP0555205A1 Dna encoding a growth factor specific for epithelial cells
08/18/1993EP0542897A4 Producing monoclonal antibodies against human t-cell receptor elements using recombinant dna vectors
08/18/1993EP0425482B1 Human insulin analogs and preparations containing them
08/18/1993CA2067837A1 Process for producing economic protein by using silkworms
08/17/1993US5236844 Dna sequences
08/17/1993US5236836 Catalyst for the hydrolysis of peptide bond in vasoactive intestinal peptide
08/17/1993US5236829 Method of producing monokine induced by gamma interferon
08/17/1993US5236825 Complexing
08/16/1993EP0652951A4 Gdf-1.
08/12/1993CA2089139A1 Complex hybrid proteins, method for preparing them, their applications as diagnostic agent, as agent intended for therapeutic use
08/11/1993EP0554670A2 Specific antibodies against activated platelets, their production and applications in diagnostics and therapeutics